ADP 2010
September, 2-4 2010, Villa Cagnola, Gazzada Schianno (VA)
In collaboration with:
Organizing secretariat
NL Congressi
Via Di Filomarino , 6 - Roma
Tel: +39 06.85.30.56.21
fax: +39 06.85.35.12.94
nl@nlcongressi.it
Preliminary Program
Thursday, September 2, 2010
14:15-16:15 SESSION 1
"INTRODUCTORY LECTURES"
Chairpersons: Marco Cattaneo (Milano, Italy)
Christian Gachet (Strasbourg, France)
Update on P2 receptors and their inhibitors
Kenneth A. Jacobson (Washington, DC)
Platelet formation
Alessandra Balduini (Pavia, Italy)
16:45-19:15 SESSION 2
"PLATELETS: PHYSIOLOGY AND PATHOLOGY"
Chairpersons: Marco Cattaneo (Milano, Italy)
Christian Gachet (Strasbourg, France)
Regulation and function of phosphatidylinositol
3-kinase in platelet integrin signaling
Mauro Torti (Pavia, Italy)
Inherited defects that affect signaling pathways
of platelets and megakaryocytes:
the present and the future
Alan Nurden (Bordeaux, France)
Platelets, adenine nucleotides and inflammation
Paolo Gresele (Perugia, Italy)
The function of CLEC-2 in platelets
Steve Watson (Birmingham, UK)
Platelets and diabetes
Giovanni Davě (Chieti, Italy)
Friday, September 3, 2010 - Morning
08:00-10:30 SESSION 3
"ANTIPLATELET DRUGS: NEW TARGETS"
VWF/GPIb axis
Hans Deckmyn (Leuven, Belgium)
P2Y1
Christian Gachet (Strasbourg, France)
GPVI
Martine Jandrot-Perrus (Paris, France)
PAR-1
Athan Kuliopulos (Boston, USA)
Syk
Patrick André (San Francisco, USA)
08:00-10:30 SESSION 4
"THE BALANCE BETWEEN EFFICACY AND SAFETY WITH
ANTIPLATELET DRUGS"
Genetic determinants of the
pharmacological response to clopidogrel
Simon Tabassome (Paris, France)
The bleeding risk in inherited
and drug-induced P2Y12 defects
Marco Cattaneo (Milano, Italy)
Tests of platelet function for monitoring antiplatelet therapy: How? When?
David Varon (Tel Aviv, Israel)
The Varying Effects of Antiplatelet Agents on In Vivo Platelet Function
Alan D. Michelson (Boston, USA)
12:15-13:00 Oral Communications
Friday, September 3, 2010 – Afternoon
15:00-17:30 SESSION 5
"ACUTE CORONARY SYNDROMES"
Therapeutic approach to patients with ACS
Robert Storey (Sheffield, UK)
Thrombin and its inhibition in ACS
Raffaele De Caterina (Chieti, Italy)
TxA2 and its inhibition in ACS
Francesco Violi (Roma, Italy)
GPIIb/IIIa and its inhibition in ACS
Kurt Huber (Vienna, Austria)
P2Y12 and its inhibiton in ACS
Paul Gurbel (Washington, USA)
18:00-19:00 Oral Communications
Saturday, September 4, 2010
08:30-11:00 SESSION 6
"OLD AND NEW P2Y12 INHIBITORS"
Clopidogrel
Giuseppe Di Pasquale (Bologna, Italy)
Prasugrel
Joe Jakubowski (Indianapolis, USA)
Ticagrelor
Diego Ardissino (Parma, Italy)
Cangrelor
Robert Storey (Sheffield, UK)
Elinogrel
Pamela Conley (San Francisco, USA)
11:30-13:00 Oral Communications
.